U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07212322) titled 'A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases' on Sept. 30.
Brief Summary: The purpose of this study is to assess the safety and efficacy of CD19 UCAR-T cell therapy in Subjects with autoimmune diseases.
Study Start Date: Oct. 10
Study Type: INTERVENTIONAL
Condition:
Systemic Lupus Erythematosus
Idiopahic Inflammatory Myopathies
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Sjogren's Syndrome
Antiphospholipid Syndrome
Immune Thrombocytopenia
Systemic Sclerosis
Intervention:
DRUG: CD19 UCAR-T cells
CD19 UCAR-T cells treatment
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Institute of Hematol...